{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,20]],"date-time":"2026-05-20T21:46:06Z","timestamp":1779313566561,"version":"3.51.4"},"reference-count":43,"publisher":"MDPI AG","issue":"2","license":[{"start":{"date-parts":[[2025,5,23]],"date-time":"2025-05-23T00:00:00Z","timestamp":1747958400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["MAKE"],"abstract":"<jats:p>This study introduces artificial intelligence as a powerful tool to transform bioequivalence (BE) trials. We apply advanced generative models, specifically Wasserstein Generative Adversarial Networks (WGANs), to create virtual subjects and reduce the need for real human participants in generic drug assessment. Although BE studies typically involve small sample sizes (usually 24 subjects), which may limit the use of AI-generated populations, our findings show that these models can successfully overcome this challenge. To show the utility of generative AI algorithms in BE testing, this study applied Monte Carlo simulations of 2 \u00d7 2 crossover BE trials, combined with WGANs. After training of the WGAN model, several scenarios were explored, including sample size, the proportion of subjects used for the synthesis of virtual subjects, and variabilities. The performance of the AI-synthesized populations was tested in two ways: (a) first, by assessing the similarity of the performance with the actual population, and (b) second, by evaluating the statistical power achieved, which aimed to be as high as that of the entire original population. The results demonstrated that WGANs could generate virtual populations with BE acceptance percentages and similarity levels that matched or exceeded those of the original population. This approach proved effective across various scenarios, enhancing BE study sample sizes, reducing costs, and accelerating trial durations. This study highlights the potential of WGANs to improve data augmentation and optimize subject recruitment in BE studies.<\/jats:p>","DOI":"10.3390\/make7020047","type":"journal-article","created":{"date-parts":[[2025,5,23]],"date-time":"2025-05-23T09:58:09Z","timestamp":1747994289000},"page":"47","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Artificial Intelligence Meets Bioequivalence: Using Generative Adversarial Networks for Smarter, Smaller Trials"],"prefix":"10.3390","volume":"7","author":[{"ORCID":"https:\/\/orcid.org\/0009-0009-0828-315X","authenticated-orcid":false,"given":"Anastasios","family":"Nikolopoulos","sequence":"first","affiliation":[{"name":"Department of Pharmacy, School of Health Sciences, National and Kapodistrian University of Athens, 15784 Athens, Greece"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0492-0712","authenticated-orcid":false,"given":"Vangelis D.","family":"Karalis","sequence":"additional","affiliation":[{"name":"Department of Pharmacy, School of Health Sciences, National and Kapodistrian University of Athens, 15784 Athens, Greece"},{"name":"Institute of Applied and Computational Mathematics, Foundation for Research and Technology Hellas (FORTH), 70013 Heraklion, Greece"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1968","published-online":{"date-parts":[[2025,5,23]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","unstructured":"Chow, S.C., Shao, J., Wang, H., and Lokhnygina, Y. (2017). Sample Size Calculations in Clinical Research, Taylor & Francis. [3rd ed.].","DOI":"10.1201\/9781315183084"},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"7","DOI":"10.4103\/0974-1208.97779","article-title":"Sample Size Estimation and Power Analysis for Clinical Research Studies","volume":"5","author":"Suresh","year":"2012","journal-title":"J. Hum. Reprod. Sci."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1148\/radiol.2272012051","article-title":"Sample size estimation: How many individuals should be studied?","volume":"227","author":"Eng","year":"2003","journal-title":"Radiology"},{"key":"ref_4","unstructured":"European Medicines Agency, Committee for Medicinal Products for Human Use (CHMP) (2025, January 15). Guideline on the Investigation of Bioequivalence. CPMP\/EWP\/QWP\/1401\/98 Rev. 1\/Corr 2010. Available online: https:\/\/www.ema.europa.eu\/en\/documents\/scientific-guideline\/guideline-investigation-bioequivalence-rev1_en.pdf."},{"key":"ref_5","unstructured":"U.S. Food and Drug Administration (FDA) (2025, January 15). Guidance for Industry: Bioavailability and Bioequivalence Studies Submitted in NDAs or INDs\u2014General Considerations. Draft Guidance, December 2013, Available online: https:\/\/www.fda.gov\/regulatory-information\/search-fda-guidance-documents\/bioavailability-and-bioequivalence-studies-submitted-ndas-or-inds-general-considerations."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"94","DOI":"10.7861\/futurehosp.6-2-94","article-title":"The potential for artificial intelligence in healthcare","volume":"6","author":"Davenport","year":"2019","journal-title":"Future Hosp. J."},{"key":"ref_7","doi-asserted-by":"crossref","unstructured":"Busnatu, \u0218., Niculescu, A.G., Bolocan, A., Petrescu, G.E.D., P\u0103duraru, D.N., N\u0103stas\u0103, I., Lupu\u0219oru, M., Geant\u0103, M., Andronic, O., and Grumezescu, A.M. (2022). Clinical applications of artificial intelligence\u2014An updated overview. J. Clin. Med., 11.","DOI":"10.3390\/jcm11082265"},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"e12100","DOI":"10.2196\/12100","article-title":"Artificial Intelligence in Clinical Healthcare Applications: Viewpoint","volume":"8","author":"Consoli","year":"2019","journal-title":"Interact. J. Med. Res."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1038\/s41591-021-01614-0","article-title":"AI in Health and Medicine","volume":"28","author":"Rajpurkar","year":"2022","journal-title":"Nat. Med."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1038\/s41586-021-03430-5","article-title":"Evaluating eligibility criteria of oncology trials using real-world data and AI","volume":"592","author":"Liu","year":"2021","journal-title":"Nature"},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1016\/j.cmrp.2019.11.005","article-title":"Current status and applications of artificial intelligence (AI) in the medical field: An overview","volume":"9","author":"Haleem","year":"2019","journal-title":"Curr. Med. Res. Pract."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"100779","DOI":"10.1016\/j.imu.2021.100779","article-title":"Data Augmentation Using Generative Adversarial Networks (GANs) for GAN-Based Detection of Pneumonia and COVID-19 in Chest X-ray Images","volume":"27","author":"Motamed","year":"2021","journal-title":"Inform. Med. Unlocked"},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/j.ejmp.2021.02.006","article-title":"AI applications to medical images: From machine learning to deep learning","volume":"83","author":"Castiglioni","year":"2021","journal-title":"Phys. Med."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1016\/j.tips.2019.05.005","article-title":"Artificial intelligence for clinical trial design","volume":"40","author":"Harrer","year":"2019","journal-title":"Trends Pharmacol. Sci."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1186\/s13063-020-04951-6","article-title":"Reporting guidelines for clinical trials of artificial intelligence interventions: The SPIRIT-AI and CONSORT-AI guidelines","volume":"22","author":"Ibrahim","year":"2021","journal-title":"Trials"},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1055\/s-0039-1677903","article-title":"Artificial intelligence in clinical decision support: Challenges for evaluating AI and practical implications","volume":"28","author":"Magrabi","year":"2019","journal-title":"Yearb. Med. Inform."},{"key":"ref_17","doi-asserted-by":"crossref","unstructured":"Shaheen, M.Y. (2021). Applications of Artificial Intelligence (AI) in Healthcare: A Review. Sci. Prepr.","DOI":"10.14293\/S2199-1006.1.SOR-.PPVRY8K.v1"},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"1716","DOI":"10.1038\/s41591-018-0213-5","article-title":"The artificial intelligence clinician learns optimal treatment strategies for sepsis in intensive care","volume":"24","author":"Komorowski","year":"2018","journal-title":"Nat. Med."},{"key":"ref_19","doi-asserted-by":"crossref","unstructured":"Amann, J., Blasimme, A., Vayena, E., Frey, D., and Madai, V.I. (2020). Explainability for artificial intelligence in healthcare: A multidisciplinary perspective. BMC Med. Inform. Decis. Mak., 20.","DOI":"10.1186\/s12911-020-01332-6"},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1016\/j.gltp.2022.04.020","article-title":"A review: Data pre-processing and data augmentation techniques","volume":"3","author":"Maharana","year":"2022","journal-title":"Glob. Transit. Proc."},{"key":"ref_21","doi-asserted-by":"crossref","unstructured":"Nikolopoulos, A., and Karalis, V.D. (2024). Implementation of a Generative AI Algorithm for Virtually Increasing the Sample Size of Clinical Studies. Appl. Sci., 14.","DOI":"10.3390\/app14114570"},{"key":"ref_22","unstructured":"Singh Walia, M. (2020). Synthetic Data Generation Using Wasserstein Conditional GANs with Gradient Penalty (WCGANS-GP). [Master\u2019s Thesis, Technological University]."},{"key":"ref_23","doi-asserted-by":"crossref","unstructured":"Solanki, A., and Naved, M. (2023). GANs for Data Augmentation in Healthcare, Springer.","DOI":"10.1007\/978-3-031-43205-7"},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"2472","DOI":"10.1007\/s10489-024-05313-4","article-title":"Wasserstein GAN-based architecture to generate collaborative filtering synthetic datasets","volume":"54","author":"Bobadilla","year":"2024","journal-title":"Appl. Intell."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"10347","DOI":"10.1007\/s11042-024-19361-y","article-title":"Understanding GANs: Fundamentals, Variants, Training Challenges, Applications, and Open Problems","volume":"84","author":"Ahmad","year":"2024","journal-title":"Multimed. Tools Appl."},{"key":"ref_26","doi-asserted-by":"crossref","unstructured":"Nikolenko, S.I. (2021). Synthetic Data for Deep Learning, Springer.","DOI":"10.1007\/978-3-030-75178-4"},{"key":"ref_27","doi-asserted-by":"crossref","unstructured":"Cascini, F., Beccia, F., Causio, F.A., Melnyk, A., Zaino, A., and Ricciardi, W. (2022). Scoping review of the current landscape of AI-based applications in clinical trials. Front. Public Health, 10.","DOI":"10.3389\/fpubh.2022.949377"},{"key":"ref_28","doi-asserted-by":"crossref","unstructured":"Karalis, V. (2016). Modeling and Simulation in Bioequivalence. Modeling in Biopharmaceutics, Pharmacokinetics and Pharmacodynamics, Springer. Interdisciplinary Applied Mathematics.","DOI":"10.1007\/978-3-319-27598-7_10"},{"key":"ref_29","doi-asserted-by":"crossref","unstructured":"Vlachou, M., and Karalis, V. (2021). An in Vitro\u2013in Vivo Simulation Approach for the Prediction of Bioequivalence. Materials, 14.","DOI":"10.3390\/ma14030555"},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1038\/s41746-023-00927-3","article-title":"Harnessing the power of synthetic data in healthcare: Innovation, application, and privacy","volume":"6","author":"Shung","year":"2023","journal-title":"NPJ Digit. Med."},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"1697","DOI":"10.1007\/s11095-021-03110-z","article-title":"A Robust Method for the Assessment of Average Bioequivalence in the Presence of Outliers and Skewness","volume":"38","author":"Burger","year":"2021","journal-title":"Pharm. Res."},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1208\/s12248-024-00981-z","article-title":"Bioequivalence of ANDA Data Using a Non-Informative Bayesian Procedure (BEST) Compared with the Two One-Sided T-Tests (TOST)","volume":"27","author":"Wang","year":"2025","journal-title":"AAPS J."},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"3648","DOI":"10.1109\/TPAMI.2022.3185316","article-title":"Rectified Wasserstein Generative Adversarial Networks for Perceptual Image Restoration","volume":"45","author":"Ma","year":"2022","journal-title":"IEEE Trans. Pattern Anal. Mach. Intell."},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"340","DOI":"10.1109\/TNNLS.2020.3027761","article-title":"Clustering Analysis via Deep Generative Models with Mixture Models","volume":"33","author":"Yang","year":"2022","journal-title":"IEEE Trans. Neural Netw. Learn. Syst."},{"key":"ref_35","first-page":"2439","article-title":"Framework Integrating Generative Model with Diffusion Technique to Improve Virtual Sample Generation","volume":"36","author":"Lin","year":"2024","journal-title":"Sens. Mater."},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1016\/j.ins.2021.05.008","article-title":"WGNCS: A Robust Hybrid Cross-Version Defect Model via Multi-Objective Optimization and Deep Enhanced Feature Representation","volume":"570","author":"Zhang","year":"2021","journal-title":"Inf. Sci."},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"103","DOI":"10.54254\/2755-2721\/83\/2024GLG0066","article-title":"An Empirical Study of WGAN and WGAN-GP for Enhanced Image Generation","volume":"83","author":"Lu","year":"2024","journal-title":"Appl. Comput. Eng."},{"key":"ref_38","unstructured":"Milne, T., and Nachman, A. (2021). Wasserstein GANs with Gradient Penalty Compute Congested Transport. arXiv."},{"key":"ref_39","doi-asserted-by":"crossref","unstructured":"Papadopoulos, D., Karali, G., and Karalis, V.D. (2024). Bioequivalence Studies of Highly Variable Drugs: An Old Problem Addressed by Artificial Neural Networks. Appl. Sci., 14.","DOI":"10.3390\/app14125279"},{"key":"ref_40","doi-asserted-by":"crossref","unstructured":"Blow, C.H., Qian, L., Gibson, C., Obiomon, P., and Dong, X. (2025). Data Augmentation via Diffusion Model to Enhance AI Fairness. Front. Artif. Intell., 8.","DOI":"10.3389\/frai.2025.1530397"},{"key":"ref_41","doi-asserted-by":"crossref","unstructured":"Ding, B., Qin, C., Zhao, R., Luo, T., Li, X., Chen, G., Xia, W., Hu, J., Luu, A.T., and Joty, S. (2024). Data Augmentation Using LLMs: Data Perspectives, Learning Paradigms and Challenges. Findings of the Association for Computational Linguistics ACL 2024, Association for Computational Linguistics.","DOI":"10.18653\/v1\/2024.findings-acl.97"},{"key":"ref_42","doi-asserted-by":"crossref","unstructured":"Papadopoulos, D., and Karalis, V.D. (2023). Variational Autoencoders for Data Augmentation in Clinical Studies. Appl. Sci., 13.","DOI":"10.3390\/app13158793"},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"100340","DOI":"10.1016\/j.health.2024.100340","article-title":"A Systematic Review of Deep Learning Data Augmentation in Medical Imaging: Recent Advances and Future Research Directions","volume":"5","author":"Islam","year":"2024","journal-title":"Healthc. Anal."}],"container-title":["Machine Learning and Knowledge Extraction"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2504-4990\/7\/2\/47\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,9]],"date-time":"2025-10-09T17:39:22Z","timestamp":1760031562000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2504-4990\/7\/2\/47"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,5,23]]},"references-count":43,"journal-issue":{"issue":"2","published-online":{"date-parts":[[2025,6]]}},"alternative-id":["make7020047"],"URL":"https:\/\/doi.org\/10.3390\/make7020047","relation":{},"ISSN":["2504-4990"],"issn-type":[{"value":"2504-4990","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,5,23]]}}}